Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the site.SummaryDifference0.0%

- Check67 days agoChange DetectedGastric cancer was added to the Conditions section. The page was updated to revision v3.4.2, and the prior government-funding lapse notice (v3.4.1) was removed.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded an informational Notice banner about a lapse in government funding and updated to Revision: v3.4.1; the change does not modify study data or eligibility details.SummaryDifference0.3%

- Check81 days agoChange DetectedUI/footer text updates include adding a 'Show glossary' control and standardizing capitalization for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision label updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.